Human Pathway-Based Disease Network

Constructing disease-disease similarity network is important in elucidating the associations between the origin and molecular mechanism of diseases, and in researching disease function and medical research. In this paper, we use a high-quality protein interaction network and a collection of pathway databases to construct a Human Pathway-based Disease Network (HPDN) to explore the relationship between diseases and their intrinsic interactions. We find that the similarity of two diseases has a strong correlation with the number of their shared functional pathways and the interaction between their related gene sets. Comparing HPDN with disease networks based on genes and symptoms respectively, we find the three networks have high overlap rates. Additionally, HPDN can predict new disease-disease correlations, which are supported by Comparative Toxicogenomics Database (CTD) benchmark and large-scale biomedical literature database. The comprehensive, high-quality relations between diseases based on pathways can further be applied to study important matters in systems medicine, for instance, drug repurposing. Based on a dense subgraph in our network, we find two drugs, prednisone and folic acid, may have new indications, which will provide potential directions for the treatments of complex diseases.

[1]  Dalin Song,et al.  Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment , 2015, Clinical interventions in aging.

[2]  K. Vousden,et al.  p53 mutations in cancer , 2013, Nature Cell Biology.

[3]  Alexandra Pohl,et al.  Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer , 2009, Pharmacogenetics and genomics.

[4]  M E Weinblatt,et al.  Methotrexate in rheumatoid arthritis. , 1988, Journal of the American Academy of Dermatology.

[5]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[6]  A. Shrim,et al.  Factors Associated with Compliance of Folic Acid Consumption among Pregnant Women. , 2017, The Israel Medical Association journal : IMAJ.

[7]  R. Lakshman,et al.  QUESTION 1: Does folic acid supplementation reduce the incidence or severity of anaemia in neonates with a positive direct Coombs test? , 2016, Archives of Disease in Childhood.

[8]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[9]  Xia Li,et al.  Community of protein complexes impacts disease association , 2012, European Journal of Human Genetics.

[10]  W. Tilley,et al.  Breast and prostate cancer: more similar than different , 2010, Nature Reviews Cancer.

[11]  Ilir Agalliu,et al.  Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study , 2015, Cancer.

[12]  Takahiro Tanaka,et al.  Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats. , 2009, Chemico-biological interactions.

[13]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[14]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2009 update , 2009, Nucleic Acids Res..

[15]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[16]  A. Kibel,et al.  Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical Trial , 2010 .

[17]  Maria Victoria Schneider,et al.  MINT: a Molecular INTeraction database. , 2002, FEBS letters.

[18]  Yang Yang,et al.  Differences of immune disorders between Alzheimer’s disease and breast cancer based on transcriptional regulation , 2017, PloS one.

[19]  Wenjun Chang,et al.  Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer , 2017, Science Signaling.

[20]  Artur Mierzecki,et al.  Association between low-dose folic acid supplementation and blood lipids concentrations in male and female subjects with atherosclerosis risk factors , 2013, Medical science monitor : international medical journal of experimental and clinical research.

[21]  Gary D Bader,et al.  BIND--The Biomolecular Interaction Network Database. , 2001, Nucleic acids research.

[22]  A. Barabasi,et al.  Human symptoms–disease network , 2014, Nature Communications.

[23]  R. Mrak,et al.  Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.

[24]  Atul J. Butte,et al.  Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..

[25]  T. Ninomiya,et al.  Diabetes mellitus and cancer risk: Review of the epidemiological evidence , 2013, Cancer science.

[26]  Shiwen Zhao,et al.  A co-module approach for elucidating drug-disease associations and revealing their molecular basis , 2012, Bioinform..

[27]  Steve Iliffe,et al.  Alzheimer’s disease , 2009, BMJ : British Medical Journal.

[28]  Gang Feng,et al.  From disease ontology to disease-ontology lite: statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations , 2009, Bioinform..

[29]  Hyunjin Kim,et al.  A literature-driven method to calculate similarities among diseases , 2015, Comput. Methods Programs Biomed..

[30]  Ming-Shiang Wu,et al.  Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. , 2010, Cancer research.

[31]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database's 10th year anniversary: update 2015 , 2014, Nucleic Acids Res..

[32]  Ramesh Chandra,et al.  Exploring the interplay between autoimmunity and cancer to find the target therapeutic hotspots , 2018, Artificial cells, nanomedicine, and biotechnology.

[33]  Jasvinder A Singh Folic acid supplementation for rheumatoid arthritis patients on methotrexate: the good gets better. , 2013, The Cochrane database of systematic reviews.

[34]  H. Brunner,et al.  From syndrome families to functional genomics , 2004, Nature Reviews Genetics.

[35]  Jinchang Wu,et al.  Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells. , 2017, Oncology reports.

[36]  Rebecca A. Betensky,et al.  Association of cancer and Alzheimer's disease risk in a national cohort of veterans , 2017, Alzheimer's & Dementia.

[37]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[38]  Susan Groshen,et al.  Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer , 2008, Pharmacogenetics and genomics.

[39]  Clare Verrill,et al.  Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer , 2017, Cold Spring Harbor molecular case studies.

[40]  Shivangi Trivedi,et al.  Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[41]  O. Tehlivets,et al.  Homocysteine as a Risk Factor for Atherosclerosis: Is Its Conversion to S-Adenosyl-L-Homocysteine the Key to Deregulated Lipid Metabolism? , 2011, Journal of lipids.

[42]  Krin A. Kay,et al.  The implications of human metabolic network topology for disease comorbidity , 2008, Proceedings of the National Academy of Sciences.

[43]  Lincoln Stein,et al.  Reactome knowledgebase of human biological pathways and processes , 2008, Nucleic Acids Res..

[44]  A. Barabasi,et al.  The impact of cellular networks on disease comorbidity , 2009, Molecular systems biology.

[45]  Q-C Luan,et al.  Ad-PUMA sensitizes ovarian cancer cells to chemotherapeutic agents. , 2015, European review for medical and pharmacological sciences.

[46]  Donald B. Johnson,et al.  Efficient Algorithms for Shortest Paths in Sparse Networks , 1977, J. ACM.

[47]  S. Ghezzi,et al.  Vascular endothelial growth factor gene variability is associated with increased risk for AD , 2005, Journal of the Neurological Sciences.

[48]  A. Barabasi,et al.  Interactome Networks and Human Disease , 2011, Cell.

[49]  M E Pickup,et al.  Clinical Pharmacokinetics of Prednisone and Prednisolone , 1979, Clinical pharmacokinetics.

[50]  O. Muskens,et al.  Graphene Oxide-Upconversion Nanoparticle Based Optical Sensors for Targeted Detection of mRNA Biomarkers Present in Alzheimer's Disease and Prostate Cancer. , 2017, ACS sensors.

[51]  Steven M. Horvath,et al.  Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.

[52]  Li Zhang,et al.  [Clinical characteristics and perinatal outcomes of non-overweight/obese pregnant women with polycystic ovary syndrome]. , 2011, Zhonghua yi xue za zhi.

[53]  H. Grosse [Diabetes and cancer]. , 1969, Archiv fur Geschwulstforschung.

[54]  D. Harlan,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[55]  S. Sleigh,et al.  Repurposing Strategies for Therapeutics , 2010, Pharmaceutical Medicine.

[56]  Peter Tugwell,et al.  Methotrexate for treating rheumatoid arthritis. , 2014, The Cochrane database of systematic reviews.

[57]  Albert-László Barabási,et al.  A Dynamic Network Approach for the Study of Human Phenotypes , 2009, PLoS Comput. Biol..

[58]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[59]  Vincent Goffin,et al.  Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge. , 2017, Pharmacology & therapeutics.

[60]  B. Cronstein,et al.  Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis , 2005, Pharmacological Reviews.

[61]  Edsger W. Dijkstra,et al.  A note on two problems in connexion with graphs , 1959, Numerische Mathematik.

[62]  A. Glicksman,et al.  Diabetes and altered carbohydrate metabolism in patients with cancer , 1956, Cancer.

[63]  Pingzhang Wang,et al.  Impairment of Granzyme B-Producing Regulatory B Cells Correlates with Exacerbated Rheumatoid Arthritis , 2017, Front. Immunol..

[64]  Tsutomu Ohta,et al.  Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 2004, Carcinogenesis.

[65]  Rong Wang,et al.  Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and beta-catenin expression in the rat. , 2008, Carcinogenesis.

[66]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[67]  Richard Bellman,et al.  ON A ROUTING PROBLEM , 1958 .

[68]  G. Eslick,et al.  Diabetes increases the risk of breast cancer: a meta-analysis. , 2012, Endocrine-related cancer.

[69]  C. Horvath,et al.  Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate. , 2000, Cancer research.

[70]  Chia-Chun Tsai,et al.  Hormone therapy for prostate cancer increases the risk of Alzheimer’s disease: a nationwide 4-year longitudinal cohort study , 2017, The aging male : the official journal of the International Society for the Study of the Aging Male.

[71]  W. Kibbe,et al.  Annotating the human genome with Disease Ontology , 2009, BMC Genomics.

[72]  Tamara Rader,et al.  Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. , 2013, The Cochrane database of systematic reviews.

[73]  H J Koch,et al.  A randomized controlled trial of prednisone in Alzheimer’s disease , 2000, Neurology.

[74]  Edward Giovannucci,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[75]  Shaneabbas Raza,et al.  27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer. , 2017, Chemistry and physics of lipids.

[76]  M Smans,et al.  Diabetes and breast cancer risk: a meta-analysis , 2012, British Journal of Cancer.

[77]  A. Rzhetsky,et al.  Probing genetic overlap among complex human phenotypes , 2007, Proceedings of the National Academy of Sciences.

[78]  Igor Jurisica,et al.  Online Predicted Human Interaction Database , 2005, Bioinform..